Toggle navigation
Home
Search
Services
Blog
Contact
About
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, H.
Uppsala University, Uppsala, Sweden
Search 93 grants from H. Adami
Search grants from Uppsala University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
University of California San Francisco
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Administrative Core
Parent-Based Treatment for Pediatric Overweight
Data Management and Statistics Core
Interactive Roles of Oxidants and Tgf-Beta in Restenosis
Multicenter Clinical Trial of ADD03055 for Partial Seizures
Recently added grants:
Structure function relationships from deep mutational scanning in human cardiomyopathy
The Human Distal Airway Aging Project
Sleep-disordered breathing in infants with myelomeningocele
Washington University Psychiatry Residency Research Education Program
Targeting Kif11 to Treat Glioblastoma Invasion and Proliferation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CP061121-000
Application #
2305384
Study Section
Project Start
1996-03-13
Project End
1998-03-12
Budget Start
1996-03-13
Budget End
1997-03-12
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Uppsala University
Department
Type
DUNS #
City
Uppsala
State
Country
Sweden
Zip Code
SE-75-1 05
Related projects
NIH 1998
N01 CP
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, Hans-Olov / Uppsala University
NIH 1997
N01 CP
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, Hans-Olov / Uppsala University
NIH 1996
N01 CP
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, H. / Uppsala University
Publications
Travis, Lois B; Hill, Deirdre A; Dores, Graca M et al.
(2003)
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
JAMA 290:465-75
Comments
Be the first to comment on this grant